Biosynthesis of heparan sulfate in EXT1-deficient cells

被引:37
|
作者
Okada, Megumi [1 ]
Nadanaka, Satomi [1 ]
Shoji, Naoko [1 ]
Tamura, Jun-ichi [2 ]
Kitagawa, Hiroshi [1 ]
机构
[1] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan
[2] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Yonago, Tottori, Japan
关键词
exostosin 1 (EXT1); exostosin 2 (EXT2); exostosin-like 2 (EXTL2); glycosaminoglycan; heparan sulfate (HS); proteoglycan; HEREDITARY MULTIPLE EXOSTOSES; EXT GENE FAMILY; CHONDROITIN SULFATE; N-ACETYLGLUCOSAMINE; TUMOR SUPPRESSORS; CHAIN INITIATION; EXPRESSION; DROSOPHILA; POLYMERIZATION; IDENTIFICATION;
D O I
10.1042/BJ20100101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HS (heparan sulfate) is synthesized by HS co-polymerases encoded by the EXT1 and EXT2 genes (exostosin 1 and 2), which are known as causative genes for hereditary multiple exostoses, a dominantly inherited genetic disorder characterized by multiple cartilaginous tumours. It has been thought that the hetero-oligomeric EXT1-EXT2 complex is the biologically relevant form of the polymerase and that targeted deletion of either EXT1 or EXT2 leads to a complete lack of HS synthesis. In the present paper we show, unexpectedly, that two distinct cell lines defective in EXT1 expression indeed produce small but significant amounts of HS chains. The HS chains produced without the aid of EXT1 were shorter than HS chains formed in concert with EXT1 and EXT2. In addition, biosynthesis of HS in EXT1-defective cells was notably blocked by knockdown of either EXT2 or EXTL2 (EXT-like), but not of EXTL3. Then, to examine the roles of EXTL2 in the biosynthesis of HS in EXT1-deficient cells, we focused on the GlcNAc (N-acetylglucosamine) transferase activity of EXTL2, which is involved in the initiation of HS chains by transferring the first GlcNAc to the linkage region. Although EXT2 alone synthesized no heparan polymers on the synthetic linkage region analogue GlcUA beta 1-3Gal beta 1-O-C2H4NH-benzyloxycarbonyl, marked polymerization by EXT2 alone was demonstrated on GlcNAc alpha 1-4GlcUA beta 1-3Gal beta 1-O-C2H4N-benzyloxycarbonyl (where GlcHA is glucuronic acid and Gal is galactose), which was generated by transferring a GlcNAc residue using recombinant EXTL2 on to GlcU beta 1-3Gal beta 1-O-C2H4NH-benzyloxycarbonyl. These findings indicate that the transfer of the first GlcNAc residue to the linkage region by EXTL2 is critically required for the biosynthesis of HS in cells deficient in EXT1.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [31] Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice
    Sgariglia, Federica
    Candela, Maria Elena
    Huegel, Julianne
    Jacenko, Olena
    Koyama, Eiki
    Yamaguchi, Yu
    Pacifici, Maurizio
    Enomoto-Iwamoto, Motomi
    BONE, 2013, 57 (01) : 220 - 231
  • [32] Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells
    Datta, Payel
    Yang, Bo
    Linhardt, Robert J.
    Sharfstein, Susan T.
    CYTOTECHNOLOGY, 2015, 67 (02) : 223 - 235
  • [33] Distinct and collaborative roles of Drosophila EXT family tumor suppressors in heparan sulfate proteoglycan biosynthesis and growth factor signaling
    Han, C
    Belenkaya, TY
    Lin, XH
    GLYCOBIOLOGY, 2004, 14 (11) : 1149 - 1149
  • [34] Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells
    Payel Datta
    Bo Yang
    Robert J. Linhardt
    Susan T. Sharfstein
    Cytotechnology, 2015, 67 : 223 - 235
  • [35] Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
    Reijmers, Rogier M.
    Groen, Richard W. J.
    Rozemuller, Henk
    Kuil, Annemieke
    de Haan-Kramer, Anneke
    Csikos, Tamas
    Martens, Anton C. M.
    Spaargaren, Marcel
    Pals, Steven T.
    BLOOD, 2010, 115 (03) : 601 - 604
  • [36] BIOSYNTHESIS OF HEPARAN-SULFATE (GLYCOSAMINOGLYCANS) BY GLOMERULAR CELLS-INVITRO
    FARIN, F
    KILLEN, P
    STRIKER, G
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 873 - 873
  • [37] Targeting EXT-1 Reveals a Crucial Role of Heparan Sulfate in the Growth of Multiple Myeloma
    Reijmers, Rogier M.
    Groen, Richard W. J.
    Rozemuller, Henk
    Kuil, Annemieke
    de Haan-Kramer, Anneke
    Csikos, Tamas
    Martens, Anton C. M.
    Spaargaren, Marcel
    Pals, Steven T.
    BLOOD, 2009, 114 (22) : 727 - 727
  • [38] A dominant negative splice variant of the heparan sulfate biosynthesis enzyme NDST1 reduces heparan sulfate sulfation
    Missaghian, Parisa
    Dierker, Tabea
    Khosrowabadi, Elham
    Axling, Fredrik
    Eriksson, Inger
    Ghanem, Abdurrahman
    Kusche-Gullberg, Marion
    Kellokumpu, Sakari
    Kjellen, Lena
    GLYCOBIOLOGY, 2022, 32 (06) : 518 - 528
  • [39] Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1
    Habuchi, Hiroko
    Kimata, Koji
    GLYCOSAMINOGLYCANS IN DEVELOPMENT, HEALTH AND DISEASE, 2010, 93 : 79 - 111